Finance

Beta
Lists
BHVN:NYSE
Biohaven Ltd
$11.01
+7.52%
(+0.77) 1D
May 29, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHVN...
Open
$10.70
High
$12.00
Low
$10.55
Mkt. cap
1.66B
Avg. vol.
2.10M
Volume
0.00
52-wk high
$18.57
52-wk low
$7.48
EPS
-$5.67
Beta
3.30
Shares outstanding
150.56M
No. of employees
274
Open
$10.70
High
$12.00
Low
$10.55
Mkt. cap
1.66B
Avg. vol.
2.10M
Volume
0.00
52-wk high
$18.57
52-wk low
$7.48
EPS
-$5.67
Beta
3.30
Shares outstanding
150.56M
No. of employees
274
News stories
From sources across the web
About Biohaven Ltd
CEO-
Employees274
Founded2022
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Websitebiohaven.com
Last report
May 4, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.69 / -$0.76
+9.68%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
184.37M
141.17M
84.93M
103.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.33M
28.21M
20.79M
26.60M
Operating expense
211.70M
169.38M
105.72M
130.43M
Total operating expenses
211.70M
169.38M
105.72M
130.43M
Operating income
-211.70M
-169.38M
-105.72M
-130.43M
Other non operating income
9.66M
-7.25M
-5.29M
-3.08M
EBT including unusual items
-197.89M
-173.22M
-145.20M
-130.26M
EBT excluding unusual items
-202.04M
-176.63M
-111.01M
-133.51M
Income tax expense
261.00K
221.00K
351.00K
272.00K
Effective tax rate
-0.13%
-0.13%
-0.24%
-0.21%
Other operating expenses
-
-
-
-
Net income
-198.15M
-173.44M
-145.56M
-130.53M
Net profit margin
-
-
-
-
Earnings per share
-1.63
-1.47
-0.90
-0.69
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-209.72M
-166.26M
-103.15M
-128.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer